Effects of misoprostol on human circulation.

Area of Science:

• Cardiovascular Pharmacology
• Prostaglandin Physiology

Background:

• Prostaglandins (PGs) of the E-type are known vasodilators but can exhibit vasoconstrictor effects in specific vascular beds.
• Misoprostol, a prostaglandin E1 (PGE1) analog, is recognized for its antiulcer properties.

Purpose of the Study:

• To investigate the effects of a single oral dose of misoprostol on the human cardiovascular system.
• To determine if misoprostol possesses clinically significant vasoconstrictive or vasodilative properties.

Main Methods:

• A double-blind, placebo-controlled, parallel group study involving twenty healthy subjects.
• Measurements included heart rate, arterial blood pressure, finger plethysmography, and limb blood flow and vascular resistance before and after oral administration of 400 mcg misoprostol or placebo.
• Data collected over a 3-hour period (1-hour baseline, 2-hour post-administration).

Main Results:

• A statistically significant decrease in heart rate was observed in the misoprostol group compared to placebo.
• A minor decrease in leg blood flow volume and a corresponding increase in leg peripheral vascular resistance were noted with misoprostol.
• These observed cardiovascular changes were not considered clinically significant.

Conclusions:

• A single 400 mcg oral dose of misoprostol does not exhibit clinically significant vasoconstrictive or vasodilative effects in humans.
• The observed minor changes in heart rate and peripheral circulation are not considered adverse or clinically important.